Targeting BCL-2 as a Therapeutic Strategy for Primary p210BCR-ABL1-positive B-ALL Cells

Background/Aim: Philadelphia-positive acute lymphoblastic leukemia (Ph(+) B-ALL) is caused by the malignant transformation of lymphoid cells induced by BCR-ABL1 constitutive catalytic activity. BCR-ABL1 tyrosine kinase inhibitors (TKIs) are effective against chronic myeloid leukemia (CML) cells, ind...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:In Vivo
Päätekijät: MASSIMINO, MICHELE, TIRRÒ, ELENA, STELLA, STEFANIA, PENNISI, MARIA STELLA, VITALE, SILVIA RITA, PUMA, ADRIANA, ROMANO, CHIARA, DI GREGORIO, SANDRA, ROMEO, MARIA ANNA, DI RAIMONDO, FRANCESCO, MANZELLA, LIVIA
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: International Institute of Anticancer Research 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157875/
https://ncbi.nlm.nih.gov/pubmed/32111748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11802
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia